Gentamicin Sulfate Cream Recalled Due to Manufacturing Practice Violations
Teligent Pharma, Inc. is recalling 31,489 tubes of Gentamicin Sulfate Cream (0.1%) nationwide due to manufacturing violations. The company discontinued its stability testing program without proper authorization.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard—discontinuation of required stability testing—is a manufacturing compliance issue rather than a confirmed product contamination or defect. This type of voluntary precautionary recall based on process deviations is classified as Moderate.
Plain-English summary
Teligent Pharma, Inc. has recalled Gentamicin Sulfate Cream USP 0.1% (NDC 70512-036-30), a prescription topical antibiotic manufactured for SOLA Pharmaceuticals, LLC, due to current Good Manufacturing Practice (cGMP) deviations. The firm discontinued its stability study program, which is required to ensure the product remains safe and effective throughout its shelf life.
The recall affects approximately 31,489 tubes distributed nationwide in the United States and Puerto Rico. The affected batches are Batch 15725 (expiration 6/30/2022) and Batch 16113 (expiration 10/31/2022). All products within their expiration dates are being recalled.
The recalled product
- Product
- Gentamicin Sulfate Cream USP, 0.1%, packaged in 30 grams tubes, Rx Only, Manufactured for: SOLA Pharmaceuticals, LLC, Baton Rouge, LA 70810, NDC 70512-036-30.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Antibiotic
- Hazard
- Affected units
- 31,489
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Batch: 15725
- Exp. 6/30/2022
- 16113
- Exp. 10/31/2022
Distribution
Part of a larger recall action
This product is one of 37 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · cgmp deviation
See all →- ModeratePritam International Recalls Brush Buddies Toothpaste Due to CGMP Deviations
FDA (Drugs) · 2026-10-28
- ModerateARU Toothpaste Recalled for CGMP Deviations
FDA (Drugs) · 2026-10-28
- ModeratePritam International Recalls Brush Buddies Fluoride Toothpaste for CGMP Deviations
FDA (Drugs) · 2026-10-28
- ModeratePritam International Recalls Brush Buddies Toothpaste Due to CGMP Deviations
FDA (Drugs) · 2026-10-28
- ModeratePritam International Recalls My Little Pony Toothpaste for CGMP Deviations
FDA (Drugs) · 2026-10-28
Similar recalls
- LowTeligent Pharma Recalls Lidocaine Ointment for Failed Stability Specifications
FDA (Drugs) · 2021-04-21
- HighFDA Recalls Lidocaine Prilocaine Cream Due to Manufacturing Compliance Issue
FDA (Drugs) · 2022-05-11
- HighFDA Recalls Lidocaine-Prilocaine Topical Cream for Manufacturing Practice Violations
FDA (Drugs) · 2022-05-04
- ModerateEconazole Nitrate Cream Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2022-04-20
- ModerateErythromycin Topical Gel Recalled Due to Manufacturing Quality Deviations
FDA (Drugs) · 2022-05-11
- ModerateBetamethasone Dipropionate Lotion recalled for failed stability test
FDA (Drugs) · 2022-01-05